BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31077962)

  • 1. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
    Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
    Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient.
    Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Hochman-Mendez C; Junior MC; Zembrzuski VM; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
    Stem Cell Res; 2019 Aug; 39():101490. PubMed ID: 31301488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
    Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives.
    Kasai-Brunswick TH; Silva Dos Santos D; Ferreira RP; Araujo DS; Dias GM; Coutinho JLA; Cruz FESF; Sternick EB; Gubert F; Oliveira JCG; Vaz IM; Borgonovo T; Brofman PRS; Moura-Neto RS; Silva R; Campos-de-Carvalho AC; Carvalho AB
    Stem Cell Res; 2018 Aug; 31():174-180. PubMed ID: 30099333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
    Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
    Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of twelve induced pluripotent stem cell lines from two healthy controls and two patients with sporadic amyotrophic lateral sclerosis.
    Yang M; Liu M; Ding Y; Vajda A; Ma J; Cui H; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2020 Apr; 44():101752. PubMed ID: 32208303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two induced pluripotent stem cell lines from two sporadic amyotrophic lateral sclerosis patients.
    Wen S; Fu S; Gao C; Lei K; Liu X
    Stem Cell Res; 2024 Feb; 74():103288. PubMed ID: 38181637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene.
    Zhang H; Ma Y; Li X; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
    Stem Cell Res; 2019 Dec; 41():101585. PubMed ID: 31775088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNF
    Bax M; Balez R; Muñoz SS; Do-Ha D; Stevens CH; Berg T; Cabral-da-Silva MC; Engel M; Nicholson G; Yang S; Blair IP; Ooi L
    Stem Cell Res; 2019 Oct; 40():101530. PubMed ID: 31445393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.
    Vlahos K; Sourris K; Mayberry R; McDonald P; Bruveris FF; Schiesser JV; Bozaoglu K; Lockhart PJ; Stanley EG; Elefanty AG
    Stem Cell Res; 2019 Jan; 34():101380. PubMed ID: 30605840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.
    Hosseini Far H; Patria YN; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 May; 37():101449. PubMed ID: 31075690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line (FMCPGHi001-A) from a 25-year-old Chinese Han healthy male donor.
    Wang T; Tang W; Zeng Q; Miao S; Pi C; Li Y; Yue W; Yu S
    Stem Cell Res; 2022 Apr; 60():102735. PubMed ID: 35247846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
    Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
    Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
    Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
    Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
    Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
    Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of ORIONi001-A induced pluripotent stem cell line for in vitro modeling of sporadic form of amyotrophic lateral sclerosis.
    Strnadel J; Zahumenska R; Nosal V; Smolar M; Marcinek J; Kalman M; Juhas S; Juhasova J; Studenovska H; Dumortier H; Chromec T; Skovierova H; Mitruskova B; Kapralik I; Mersakova S; Brany D; Halasova E
    Stem Cell Res; 2020 Oct; 48():101981. PubMed ID: 32919353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.